110 results
Prognostic value of tricuspid valve gradient after transcatheter edge-to-edge repair : insights from the TriValve registry
17 Apr 2023
The present study aimed to address the association between the mean TVG at discharge and outcomes among patients who underwent tricuspid TEER within the TriValve Registry.

Reviewer

Minimally invasive vs conventional sternotomy for mitral valve repair surgery: An expertise based multicentre randomised controlled trial (UK Mini Mitral)
07 Mar 2023
Reported from ACC 2023 / WCC
Edoardo Zancanaro provides his take on this clinical trial presented by Enoch Akowuah at the American College of Cardiology Scientific Session (ACC.23/WCC).

Author

2-year outcomes of transcatheter mitral valve replacement in patients with annular calcification, rings, and bioprostheses
26 Jan 2023
The aim of this study is to present the TMVR results at 2 years from the MITRAL population.

Reviewer

Mitral edge-to-edge repair: surgical and transcatheter approaches - LIVE case
29 Nov 2022 – From PCR London Valves 2022
Learn from these 2 cases of primary mitral repair using percutaneous and surgical approaches:
- LIVE case - A 90-year-old male with history of LAD PCI 23 years ago and paroxysmal atrial fibrillation presents a primary mitral regurgitation (P2 prolapse) on mildly dilated LV and preserved LV function.
The operators...

Patient-prosthesis mismatch: surgical and transcatheter approaches - LIVE case
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover different surgical and transcatheter approaches:
- Part 1: Bioprosthesis aortic valve stenosis
A 73-year-old male, with diabetes, BMI 29, atrial fibrillation, history of SAVR 15 years ago (Perimount 27) presents a symptomatic severe surgical valve stenosis with a preserved LV function.
During the live time...

Learning from the Masters: Antonio Colombo - why did I choose to become an interventional cardiologist?
31 Oct 2022
Discover our new series entitled "Learning from the Masters"!
The aim of this series is to contribute to the understanding of the NextGen of how the field has evolved over the past decades, as they look toward the future of interventional cardiology & cardiac surgery.
In this...

Left main stem percutaneous coronary intervention: does on-site surgical cover make a difference?
28 Oct 2022
The current analysis examines patient characteristics and outcomes following LM PCI performed in NSC in England and Wales.

Reviewer

Reviewer

Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials
07 Oct 2022 – From AICT-AsiaPCR 2022
Take advantage of this AICT-AsiaPCR 2022 session to learn in detail about the FAME 3 and MASTER-DAPT trials and how to use their results in daily practice, and to better understand what is behind the term "non-inferiority" and when and how to choose a non-inferiority margin.

Revascularisation for Ischemic heart failure: is PCI as good as CABG?
27 Sep 2022
Pamela Gatto interviews Volkmar Falk, Cardiovascular Surgeon, and Dejan Milasinovic, Interventional Cardiologist, to get their perspective about the results of the REVIVED-BCIS2 trial.
The 3 questions are:
- What were your first thoughts and feelings when the findings from REVIVED were presented at ESC 2022?
- In STICH(es), CABG had a...

BYPASS-CTCA: The value of computed tomography cardiac angiography in improving patient satisfaction and reducing contrast load, procedural duration and complications in patients who had previous CABG undergoing invasive coronary angiography
19 Sep 2022
Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.
It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.

Author
